NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









iO Urology

iO Urology

Private
Knoxville, TennesseeHealthcare & Life Scienceshttps://www.carepathurology.com/

Last Round

Series A

Mar 29, 2024

Total Funding Raised

$38.85M

Company Overview

iO Urology is a medical technology company that has developed the CarePath® platform, an FDA-approved digital diagnostic tool for remote urologic care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine, Patient Engagement

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

uroflowmetryremote patient monitoringRPMurology diagnostic devicepoint-of-care diagnosticsdigital healthtelemedicinelower urinary tract symptomsLUTSIoMTinternet of medical thingsbladder function monitoringat-home testingconnected healthvirtual care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iO Urology Comparables

Compare iO Urology with similar companies based on industry and business-model similarity.

iO Urology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

iO Urology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 29, 2024
Series ADec 19, 2023
GrantMar 21, 2023

Key People

Founding team and executive leadership

Keith Moore

Chief Technology Officer

Executive Team

iO Urology Investors

Notable investors and investment history

iO Urology investors
InvestorRounds
Jumpstart CapitalSeries A
Tennessee Technology Development CorporationSeries A
Solas BioVenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 29, 2024

    $19.4M round led by Solas BioVentures.

iO Urology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iO Urology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iO Urology's valuation, stock price, and market status.

Firmographic Details

HeadquartersKnoxville, Tennessee
Employee Range15
Year Founded2015
Last FundingMar 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.